Allogene Therapeutics, Inc. (ALLO)
2.60
+0.12
(+4.84%)
USD |
NASDAQ |
Apr 06, 16:00
2.63
+0.03
(+1.15%)
After-Hours: 20:00
Allogene Therapeutics SG&A Expense (TTM) : 56.78M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 317.74M |
| Inovio Pharmaceuticals, Inc. | 32.68M |
| Vaxart, Inc. | 17.61M |
| Capricor Therapeutics, Inc. | 23.69M |
| Agenus, Inc. | 54.39M |